Beta Bionics to Announce First Quarter 2025 Financial Results on May 6, 2025
Beta Bionics (Nasdaq: BBNX), a leader in advanced diabetes management solutions, has scheduled the release of its first quarter 2025 financial results for Tuesday, May 6, 2025, after market close.
The company will host a conference call and simultaneous webcast at 4:30 PM Eastern Time (1:30 PM Pacific Time) on the same day. Investors can access the live call by dialing (888) 596-4144 with passcode 8363701. The webcast will be available in the Investors—Events & Presentations section of the company's website and will be archived for future viewing.
Beta Bionics (Nasdaq: BBNX), leader nelle soluzioni avanzate per la gestione del diabete, ha programmato la pubblicazione dei suoi risultati finanziari del primo trimestre 2025 per martedì 6 maggio 2025, dopo la chiusura del mercato.
La società terrà una conference call e una webcast simultanea alle 16:30 ora della costa orientale (13:30 ora della costa pacifica) dello stesso giorno. Gli investitori potranno partecipare alla chiamata dal vivo componendo il numero (888) 596-4144 con il codice di accesso 8363701. La webcast sarà disponibile nella sezione Investitori—Eventi e Presentazioni del sito web aziendale e resterà archiviata per la visione futura.
Beta Bionics (Nasdaq: BBNX), líder en soluciones avanzadas para el manejo de la diabetes, ha programado la publicación de sus resultados financieros del primer trimestre de 2025 para el martes 6 de mayo de 2025, después del cierre del mercado.
La compañía realizará una llamada conferencia y una transmisión simultánea a las 4:30 PM hora del Este (1:30 PM hora del Pacífico) ese mismo día. Los inversionistas podrán acceder a la llamada en vivo marcando el (888) 596-4144 con el código de acceso 8363701. La transmisión estará disponible en la sección Inversionistas—Eventos y Presentaciones del sitio web de la empresa y quedará archivada para visualización futura.
Beta Bionics (나스닥: BBNX)는 첨단 당뇨병 관리 솔루션 분야의 선두주자로, 2025년 1분기 재무 결과를 2025년 5월 6일 화요일 장 마감 후에 발표할 예정입니다.
회사는 같은 날 동부 시간 오후 4시 30분 (태평양 시간 오후 1시 30분)에 컨퍼런스 콜과 동시 웹캐스트를 진행합니다. 투자자들은 (888) 596-4144번으로 접속 코드 8363701을 입력하여 실시간 통화에 참여할 수 있습니다. 웹캐스트는 회사 웹사이트의 투자자—이벤트 및 프레젠테이션 섹션에서 시청 가능하며, 이후 다시 볼 수 있도록 아카이브됩니다.
Beta Bionics (Nasdaq : BBNX), leader dans les solutions avancées de gestion du diabète, a programmé la publication de ses résultats financiers du premier trimestre 2025 pour le mardi 6 mai 2025, après la clôture du marché.
La société organisera une conférence téléphonique et une webdiffusion simultanée à 16h30 heure de l’Est (13h30 heure du Pacifique) le même jour. Les investisseurs pourront accéder à l’appel en direct en composant le (888) 596-4144 avec le code d’accès 8363701. La webdiffusion sera disponible dans la section Investisseurs—Événements & Présentations du site web de l’entreprise et sera archivée pour une consultation ultérieure.
Beta Bionics (Nasdaq: BBNX), ein führendes Unternehmen im Bereich fortschrittlicher Diabetes-Management-Lösungen, hat die Veröffentlichung seiner Finanzergebnisse für das erste Quartal 2025 für Dienstag, den 6. Mai 2025, nach Börsenschluss angekündigt.
Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time (13:30 Uhr Pacific Time) eine Telefonkonferenz und eine gleichzeitige Webcast-Veranstaltung abhalten. Investoren können die Live-Konferenz unter der Nummer (888) 596-4144 mit dem Zugangscode 8363701 verfolgen. Der Webcast wird im Bereich Investoren—Events & Präsentationen auf der Firmenwebsite verfügbar sein und für spätere Ansicht archiviert.
- None.
- None.
IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its first quarter 2025 financial results after the financial markets close on Tuesday, May 6, 2025. In connection with the release, management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time).
The link to the webcast will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay. You may also access the live call by dialing (888) 596-4144, passcode is 8363701.
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
When will Beta Bionics (BBNX) release Q1 2025 earnings?
How can I join the Beta Bionics (BBNX) Q1 2025 earnings call?
What time is the Beta Bionics (BBNX) Q1 2025 earnings call?
Where can I find the replay of Beta Bionics (BBNX) Q1 2025 earnings webcast?
